| abstract |
The invention relates to derivatives corresponding to the general formula (I), in which R1 represents a C5-26-alkyl, C5-26-alkenyl or C5-26-alkynyl group or a polyunsaturated aliphatic carbon group comprising between 5 and 26 carbon atoms and comprising at least two unsaturations chosen from double and triple bonds; R2 represents a hydrogen atom or a C1-6-alkyl group; R3 repreents a hydrogen atom or a C1-3-alkyl group; R4 represents a hydrogen atom or a C1-4- alkyl, C3-7-cycloalkyl or C3-7-cycloalkyl-C1-3-alkyl group; in the base, hydrate or solvate form. Preparation process and application in therapeutics. |